For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and the formulated version represents a significant breakthrough . These groundbreaking therapies stabilize the transthyretin protein, slowing its destructive build-up and alleviating the burden of the condition . Patien